Wegovy is also manufactured by Novo Nordisk
Meshkat S, Di Luciano C, Swiderski A, Li G, Aguilar RJ, Dunkley BT, Reichelt AC, Zhang Y, Greenshaw A, Vermetten E, Jetly R, Dash S, Agarwal SM, Swainson J, Bhat V (2025) Efficacy and Safety of Glucagon-Like Peptide-1 Agonists for Psychiatric Symptoms: A Systematic Review
Most users notice changes between weeks 3 and 6 of treatment, often after reaching doses of 2mg weekly or higher
The glucagon receptor increases energy expenditure, and many people report a subtle but noticeable increase in baseline energy once they reach the 4 to 8mg dose range
Several RCT investigated the role of liraglutide, alone or in combination with metformin, in women with PCOS and overweight or obesity, confirming its beneficial effect on anthropometric and metabolic features 95